Combination of Three Unique Anti-Tumor Modalities Engineered into iPSC-Derived T Cells Demonstrate a Synergistic Effect in Overcoming Tumor Heterogeneity and Cancer Escape
Blood (2021) 138 (Supplement 1): 2793.
Currently there are no citedby results. Try again later.
